Get started
MIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLUMIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLUMIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLU

MIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLU

No trades
See on Supercharts
Overview Chart Analysis
Holdings
Discussions Technicals Seasonals

MIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLU holdings


As of August 8, 2025
Symbol
Weight %
Shares
Market value
L
LLYEli Lilly and Company
23.62%
‪‪14.32 K‬‬
‪‪12.44 B‬‬KRW
N
NVONovo Nordisk A/S Sponsored ADR Class B
18.00%
‪‪133.66 K‬‬
‪‪9.48 B‬‬KRW
A
ABBVAbbVie, Inc.
13.30%
‪‪25.47 K‬‬
‪‪7.01 B‬‬KRW
R
RORoche Holding Ltd
9.22%
‪‪10.95 K‬‬
‪‪4.86 B‬‬KRW
A
AZNAstraZeneca PLC Sponsored ADR
8.75%
‪‪45.09 K‬‬
‪‪4.61 B‬‬KRW
N
NVSNovartis AG Sponsored ADR
8.34%
‪‪27.08 K‬‬
‪‪4.40 B‬‬KRW
M
MRKMerck & Co., Inc.
7.64%
‪‪35.92 K‬‬
‪‪4.03 B‬‬KRW
A
AMGNAmgen Inc.
5.80%
‪‪7.63 K‬‬
‪‪3.05 B‬‬KRW
4
4519Chugai Pharmaceutical Co., Ltd.
3.11%
‪‪28.65 K‬‬
‪‪1.64 B‬‬KRW
R
REGNRegeneron Pharmaceuticals, Inc.
2.29%
‪‪1.54 K‬‬
‪‪1.21 B‬‬KRW
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.